Avalon GloboCare Secures $2.8M Net from Private Placement, Adding Warrants
ALBT has more than doubled off its 52-week low of $0.42 on elevated volume (6.7× avg).
Summary
Avalon GloboCare Corp. has completed a private placement, raising approximately $2.8 million in net proceeds. This financing involved the issuance of common shares and pre-funded warrants, along with Series A-1 and A-2 warrants, and granted investors registration rights. The deal, which closed on February 27, 2026, provides crucial capital for operating expenses and working capital. While the gross proceeds of $3.25 million and the closing of the private placement were previously announced, including in an 8-K filed earlier today, the disclosure of the $2.8 million net proceeds offers a more precise understanding of the actual cash infusion. This significant capital raise, representing a substantial portion of the company's market capitalization, is highly dilutive but essential for the company's liquidity and operations. Traders will monitor how this capital is deployed and the impact of the warrants on future share structure.
At the time of this announcement, ALBT was trading at $1.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8M. The 52-week trading range was $0.42 to $11.66. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Unknown.